<?xml version="1.0" encoding="utf-8"?><!-- generator="wordpress/1.2.2" -->
<rss version="0.92">
    <channel>
        <title>licenblog</title>
        <link>http://licenblog.licenscape.com</link>
        <description>babblings!</description>
	<lastBuildDate>Wed, 22 Feb 2006 16:49:40 +0000</lastBuildDate>
        <docs>http://backend.userland.com/rss092</docs>

        <item>
            <title>Golden exclusivity</title>
            <description>After Japan, the Pravastatin - the revolutionary drug for hyperlididemia is moving to the generic realm in US as well. Licenblog is a joint blog - post or send comments to licenblog@licenscape.com  </description>
            <link>http://licenblog.licenscape.com/index.php?p=4</link>
        </item>
        <item>
            <title>The end of Pravastatin age</title>
            <description>The following enigmatic announcement has been posted at the web site of Daiichi Sankyo on February 17, 2006. Neither BMS nor Watson has any references for the announcement.Future Business Prospects of the Hyperlipidemia Drug Pravastatin in the United StatesTokyo, February 17, 2006 - DAIICHI SANKYO COMPANY, LIMITED has announced today ...</description>
            <link>http://licenblog.licenscape.com/index.php?p=3</link>
        </item>
        <item>
            <title>Privacy hurts</title>
            <description>A new, although not unexpected findings were summarized in the article posted at the web site of The Daily Yomiuri (with omissions):Surveys feel pinch of privacy / Information protection law making public opinion hard to tapThe law that went into full effect last year to protect personal privacy is impairing ...</description>
            <link>http://licenblog.licenscape.com/index.php?p=2</link>
        </item>
        <item>
            <title>Welcome!</title>
            <description>Welcome to Licenblog! Licenblog is a joint blog - post or send comments to licenblog@licenscape.com   </description>
            <link>http://licenblog.licenscape.com/index.php?p=1</link>
        </item>
    </channel>
</rss>
